Status:
COMPLETED
Sleepiness and Brain Function: The Effect of Armodafinil in Shift Work Sleep Disorder
Lead Sponsor:
Henry Ford Health System
Collaborating Sponsors:
Cephalon
Conditions:
Shift Work Sleep Disorder
Eligibility:
All Genders
18-55 years
Brief Summary
The investigators hypothesize that in patients with shift work sleep disorder, armodafinil will specifically increase brain activity in the frontal cortex parallel with improvements in deficits of fun...
Detailed Description
The current protocol will utilize a paradigm which is well suited to examine frontal attentional neuronal mechanisms by eliciting event related potential components known to reflect automatic stimulus...
Eligibility Criteria
Inclusion
- Night shift workers with and without shift work sleep disorder.
Exclusion
- Secondary condition to shift work sleep disorder.
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00688142
Start Date
February 1 2008
End Date
March 1 2010
Last Update
March 31 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Hospital Sleep Disorders & Research Center
Detroit, Michigan, United States, 48202